David Voigt, MD
Surgery · Lincoln, NENPI 1831123389
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,012 of the $1,171 with a category attached, or 86.4%. 5 manufacturers reported payments, led by Access Pro Medical, LLC at 34.0% of the total. Reporting peaked in 2023 at $413 and has fallen 58.0% since, to $173 in 2025. That places this record below the midpoint for surgery clinicians in NE, where the typical reported total is $1,000.
Across 27 payments — averaging $43.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Access Pro Medical, LLC$398
- Medline Industries LP$312
- Smith+Nephew$184
- Integra Lifesciences Corporation$159
- Kerecis Limited$118
What the payments were for
- Food & beverage$1,01286%
- Other$15914%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Access Pro Medical, LLC | 7 | $398 |
| Medline Industries LP | 5 | $312 |
| Smith+Nephew | 11 | $184 |
| Integra Lifesciences Corporation | 1 | $159 |
| Kerecis Limited | 3 | $118 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CYTAL$159
How this compares
$1,171 in reported general payments places this provider in the 50th percentile of 197 surgery providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 53 | $3,103 |
| SulfamylonMafenide Acetate | 13 | $2,292 |
| Fluconazole | 20 | $545 |
| SsdSilver Sulfadiazine | 22 | $520 |
| Silver Sulfadiazine | 22 | $458 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 26 | $279 |
| Gabapentin | 22 | $229 |
| Levofloxacin | 33 | $215 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $87 |
Paid to pharmacies, not to this prescriber.
Other surgery in Lincoln
- Benjamin HungLincoln$75K
- Anthony TabatabaiLincoln$17K
- Clinton RathjeLincoln$14K
- Jordan BowlingLincoln$11K
- Melanie McCormickLincoln$4K
- Dmitry OleynikovOmaha$180K
- Gary AnthoneOmaha$71K
- Jason WalshKearney$58K
- Moriah WrightOmaha$37K
- Andy YangOmaha$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.